Could a targeted chest nerve block take the sting out of pacemaker surgery?

NCT ID NCT07739407

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether adding an ultrasound-guided PECS II block—a numbing injection between chest muscles—to standard local anesthesia can reduce pain during permanent pacemaker implantation. About 72 adults scheduled for the procedure will be randomly assigned to receive either the extra block or standard care alone. The main focus is pain intensity while the pacemaker pocket is created, with secondary measures including painkiller use, satisfaction, and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ultrasound-guided PECS II block (injection of bupivacaine between chest muscles)
What this could lead to
If effective, this approach could offer a simple, drug-sparing way to make pacemaker implantation more comfortable, reducing pain and the need for extra painkillers during and after the procedure.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The block carries small risks like bleeding, infection, or nerve damage, and it may not provide meaningful extra pain relief beyond standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC PACING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.